{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:03:05Z","timestamp":1792728185662,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajkd.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1053\/j.ajkd.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:06:07Z","timestamp":1629417967000},"page":"527-538.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Population Epidemiology of Hyperkalemia: Cardiac and Kidney Long-term Health Outcomes"],"prefix":"10.1053","volume":"79","author":[{"given":"Andrew","family":"Mclean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintu","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2021.07.008_bib1","author":"Alfonzo"},{"issue":"1","key":"10.1053\/j.ajkd.2021.07.008_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","article-title":"Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"97","author":"Clase","year":"2020","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2021.07.008_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/dme.13687","article-title":"Hyperkalaemia in people with diabetes: occurrence, risk factors and outcomes in a Danish population-based cohort study","volume":"35","author":"Thomsen","year":"2018","journal-title":"Diabet Med"},{"issue":"9","key":"10.1053\/j.ajkd.2021.07.008_bib5","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/ndt\/gfx312","article-title":"Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes\u2014a Danish population-based cohort study","volume":"33","author":"Thomsen","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2021.07.008_bib6","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.amjcard.2016.08.078","article-title":"Serum potassium levels and outcome in patients with chronic heart failure","volume":"118","author":"Hoss","year":"2016","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1053\/j.ajkd.2021.07.008_bib7","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.amjmed.2016.03.008","article-title":"Prevalence and prognosis of hyperkalemia in patients with acute myocardial infarction","volume":"129","author":"Grodzinsky","year":"2016","journal-title":"Am J Med"},{"issue":"10","key":"10.1053\/j.ajkd.2021.07.008_bib8","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ajh\/hpy101","article-title":"Serum potassium and cardiovascular events in heart failure with preserved left ventricular ejection fraction patients","volume":"31","author":"Nishihara","year":"2018","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1053\/j.ajkd.2021.07.008_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12882-019-1250-0","article-title":"Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England","volume":"20","author":"Horne","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.ajkd.2021.07.008_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2017.07.035","article-title":"Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system","volume":"245","author":"Nilsson","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.ajkd.2021.07.008_bib11","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1053\/j.ajkd.2021.07.008_bib12","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2021.07.008_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.resuscitation.2005.10.004","article-title":"European resuscitation council guidelines for resuscitation 2005. section 7. cardiac arrest in special circumstances","volume":"67","author":"Soar","year":"2005","journal-title":"Resuscitation"},{"issue":"17","key":"10.1053\/j.ajkd.2021.07.008_bib14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/eurheartj\/ehy100","article-title":"Serum potassium and adverse outcomes across the range of kidney function: A CKD prognosis consortium meta-analysis","volume":"39","author":"Kovesdy","year":"2018","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1053\/j.ajkd.2021.07.008_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1053\/j.ajkd.2021.07.008_bib16","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.ajkd.2021.07.008_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.12651018","article-title":"Sodium zirconium cyclosilicate among individuals with hyperkalemia: a 12-month phase 3 study","volume":"14","author":"Spinowitz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2021.07.008_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: consensus report of the acute disease quality initiative (ADQI) 16 workgroup","volume":"13","author":"Chawla","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2021.07.008_bib19","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/ejhf.1793","article-title":"Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. data from 9222 chronic heart failure patients of the ESC-HFA-EORP heart failure long-term registry","volume":"22","author":"Rossignol","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1053\/j.ajkd.2021.07.008_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"Yusuf","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"9386","key":"10.1053\/j.ajkd.2021.07.008_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"issue":"40","key":"10.1053\/j.ajkd.2021.07.008_bib22","first-page":"5514","article-title":"Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy. Article in Danish","volume":"163","author":"Parving","year":"2001","journal-title":"Ugeskr Laeger"},{"issue":"3","key":"10.1053\/j.ajkd.2021.07.008_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Heart Outcomes Prevention Evaluation Study Investigators; Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"27","key":"10.1053\/j.ajkd.2021.07.008_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1053\/j.ajkd.2021.07.008_bib25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2021.07.008_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.kint.2017.02.019","article-title":"Post-discharge kidney function is associated with subsequent ten-year renal progression risk among survivors of acute kidney injury","volume":"92","author":"Sawhney","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2021.07.008_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ajkd.2016.05.018","article-title":"Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study","volume":"69","author":"Sawhney","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2021.07.008_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019435","article-title":"Acute kidney injury in the UK: a replication cohort study of the variation across three regional populations","volume":"8","author":"Sawhney","year":"2018","journal-title":"BMJ Open"},{"issue":"4","key":"10.1053\/j.ajkd.2021.07.008_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"Von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.ajkd.2021.07.008_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0004563212474566","article-title":"The impact of centrifugation in primary care on pseudohyperkalaemia: a retrospective evaluation","volume":"50","author":"Turner","year":"2013","journal-title":"Ann Clin Biochem"},{"issue":"9","key":"10.1053\/j.ajkd.2021.07.008_bib32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2021.07.008_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006497","article-title":"Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review","volume":"5","author":"Sawhney","year":"2015","journal-title":"BMJ Open"},{"issue":"2","key":"10.1053\/j.ajkd.2021.07.008_bib34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1536867X0400400201","article-title":"Cumulative incidence estimation in the presence of competing risks","volume":"4","author":"Coviello","year":"2004","journal-title":"Stata J"},{"issue":"9","key":"10.1053\/j.ajkd.2021.07.008_bib35","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/ndt\/gfy249","article-title":"Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine measurements (SCREAM) project","volume":"34","author":"Gasparini","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2021.07.008_bib36","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1186\/cc11872","article-title":"Severe hyperkalemia requiring hospitalization: predictors of mortality","volume":"16","author":"An","year":"2012","journal-title":"Crit Care"},{"key":"10.1053\/j.ajkd.2021.07.008_bib37","series-title":"Stata Statistical Software: Release 16","year":"2019"},{"issue":"3","key":"10.1053\/j.ajkd.2021.07.008_bib38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls","volume":"41","author":"Andersen","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1053\/j.ajkd.2021.07.008_bib39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"446","key":"10.1053\/j.ajkd.2021.07.008_bib40","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621007988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621007988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T02:25:52Z","timestamp":1721010352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638621007988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0272638621007988"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.07.008","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population Epidemiology of Hyperkalemia: Cardiac and Kidney Long-term Health Outcomes","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}